Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Breast 1

Conditions

Multiple Myeloma 7Breast Neoplasms 6Neoplasms, Plasma Cell 5Neoplasm Metastasis 3Pain 2Spondylitis, Ankylosing 1Prostatic Neoplasms 1Bone Diseases 1

Interventions

Fentanyl 23Analgesia 22Morphine 19Acupuncture Therapy 18Zoledronic Acid 15Oxycodone 14Acetaminophen 14Ketamine 13Radiotherapy 12Therapeutics 11Methadone 11Lidocaine 11nabiximols 10Ibandronic Acid 10Hydromorphone 10Bupivacaine 10Surveys and Questionnaires 8Ropivacaine 8Psychiatric Rehabilitation 7Early Intervention, Educational 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5Massage 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pain × Pamidronate × Clear all
NCT00482378 2018-08-14

Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain

Mayo Clinic

Phase 1/2 Completed
39 enrolled
Plasma cell

Multiple Myeloma, Pain, Neoplasms, Plasma Cell

NCT01907880 2017-07-07

ER11-03

Ottawa Hospital Research Institute

Phase 4 Completed
74 enrolled
Breast

Breast Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡